Identification of novel genetic loci contributing to 12-O-tetradecanoylphorbol-13-acetate skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice

Cancer Research

Volumn 63, Issue 11, 2003, Pages 2747-2751

  Angel, Joe M ^a   Caballero, Manuel ^a   DiGiovanni, John ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN; PROTEIN PSL 1; PROTEIN PSL 2; PROTEIN PSL 3; PROTEIN PSL 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME 1; CHROMOSOME 2; GENE LOCUS; GENE MAPPING; GENETIC MARKER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SKIN TUMOR;

ANIMALS; CARCINOGENS; CHROMOSOME MAPPING; CHROMOSOMES, MAMMALIAN; COCARCINOGENESIS; CROSSES, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; LINKAGE (GENETICS); MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE;

EID: 0037601788     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Perera, F. P. Molecular epidemiology: insights into cancer susceptibility, risk assessment and prevention. J. Natl. Cancer Inst. (Bethesda), 88: 496-509, 1996.
2. Ponder, B. A. J. Inherited predisposition to cancer. Trends Genet., 6: 213-218, 1990.
3. DiGiovanni, J. Genetic determinants of cancer susceptibility. In: G. T. Bowden and S. M. Fischer (eds.), Comprehensive Toxicology, Carcinogens and Anticarcinogens, Vol. 10, pp. 425-451. New York: Pergamon Press, 1997.
4. Angel, J. M., Morizot, D. C., and Richie, E. R. Localization of a novel chromosome 7 locus that suppresses development of N-methyl-N-nitrosourea-induced murine thymic lymphomas. Mol. Carcinog., 7: 151-156, 1993.
5. Angel, J. M., Beltran, L., Minda, K., Rupp, T., and DiGiovanni, J. Association of a murine chromosome 9 locus (Psl1) with susceptibility to mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Mol. Carcinog., 20: 162-167, 1997.
6. Angel, J. M., Popova, N., Lanko, N., Turusov, V. S., and DiGiovanni, J. A locus that influences susceptibility to 1,2-dimethylhydrazine-induced colon tumors maps to the distal end of mouse chromosome 3. Mol. Carcinog., 27: 47-54, 2000.
7. Richie, E. R., Angel, J. M., and Rinchik, E. M. Tlag1, a novel murine tumor susceptibility gene that regulates MNU-induced thymic lymphoma development. In: J. Groopman, C. Walker, A. Klein-Szanto, and T. S. Slaga (eds.), Genetics and Susceptibility: Impact on Risk Assessment, pp. 23-32. New York: Wiley Liss, 1996.
8. Dietrich, W. F., Lander, E. S., Smith, J. S., Moser, A. R., Gould, K. A., Luongo, C., Borenstein, N., and Dove, W. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell, 75: 531-639, 1993.
9. Festing, M. F. W., Yang, A., and Malkinson, A. M. At least four genes and sex are associated with susceptibility to urethane-induced pulmonary adenomas in mice. Genet. Res., 64: 99-106, 1994.
10. Fijneman, R. J. A., Oomen, L. C. J. M., Snoek, M., and Demant, P. A susceptibility gene for alveolar lung tumors in the mouse maps between Hsp703 and G7 within the H2 complex. Immunogenetics, 41: 106-109, 1995.
11. Fijneman, R. J. A., de Vries, S. S., Jansen, R. C., and Demant, P. Complex interactions of new quantitative trait loci Sluc1 Sluc2 Sluc3 Sluc4 that influence the susceptibility to lung cancer in the mouse. Nat. Genet., 14: 465-467, 1996.
12. Gariboldi, M., Manenti, G., Canzian, F., Falvella, F. S., Pierotti, M. A., Porta, G. D., Binelli, G., and Dragani, T. A. Chromosome mapping of murine susceptibility loci to liver carcinogenesis. Cancer Res., 53: 209-211, 1993.
13. Hsu, L-C., Kennan, W. S., Shepel, L. A., Jacob, H. J., Szpirer, J., Lander, E. S., and Gould, M. N. Genetic identification of Mcs-1, a rat mammary carcinoma suppressor gene. Cancer Res., 54: 2765-2770, 1994.
14. Jacoby, R. F., Hohman, C., Marshall, D. J., Frick, T. J., Schlack, S., Broda, M., Smutko, J., and Elliott, R. W. Genetic analysis of colon cancer susceptibility in mice. Genomics, 22: 381-387, 1994.
15. Lee, G-H., and Drinkwater, N. R. The Hcr (hepatocarcinogen resistance) loci of DBA/2J mice partially suppress phenotypic expression of the Hcs (hepatocarcinogen sensitivity) loci of C3H/HeJ. Carcinogenesis (Lond.), 16: 1993-1996, 1995.
16. Lee, G-H., Bennett, L. M., Carabeo, R. A., and Drinkwater, N. R. Identification of hepatocarcinogen-resistance genes in DBA/2 mice. Genetics, 139: 387-395, 1995.
17. Manenti, G., Binelli, G., Gariboldi, M., Canzian, F., De Gregorio, L., Falvella, F. S., Dragani, T. A., and Pierotti, M. A. Multiple loci affect genetic predisposition to hepatocarcinogenesis in mice. Genomics, 23: 118-124, 1994.
18. Manenti, G., Gariboldi, M., Fiorino, A., Zanesi, N., Pierotti, M. A., and Dragani, T. A. Genetic mapping of lung cancer modifier loci specifically affecting tumor initiation and progression. Cancer Res., 57: 4164-4166, 1997.
19. Mock, B. A., Krall, M. M., and Dosik, J. K. Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis. Proc. Natl. Acad. Sci. USA, 90: 9499-9503, 1993.
20. Mock, B. A., Lowy, D. T., Rehman, I., Padlan, C., Yuspa, S. H., and Hennings, H. Multigenic control of skin tumor susceptibility in SENCARA/Pt mice. Carcinogenesis (Lond.), 19: 1109-1115, 1998.
21. Moen, C. J. A., Snoek, M., Hart, A. A. M., and Demant, P. Scc-1, a novel colon cancer susceptibility gene in the mouse: linkage to CD44 (Ly-24 Pgp-1) on chromosome 2. Oncogene, 7: 563-566, 1992.
22. Moen, C. J. A., Groot, P. C., Hart, A. A. M., Snoek, M., and Demant, P. Fine mapping of colon tumor susceptibility (Scc) genes in the mouse different from the genes known to be somatically mutated in colon cancer. Proc. Natl. Acad. Sci. USA, 93: 1082-1086, 1996.
23. Muhlbock, O., and Dux, A. Histocompatibility genes (the H-2 complex) and susceptibility to mammary tumor virus in mice. J. Natl. Cancer Inst. (Bethesda), 53: 993-996, 1974.
24. Nagase, H., Bryson, S., Cordell, H., Kemp, C. J., Fee, F., and Balmain, A. Distinct genetic loci control development of benign and malignant skin tumours in mice. Nat. Genet., 10: 424-429, 1995.
25. Nagase, H., Mao, J-M., and Balmain, A. A subset of skin tumor modifier loci determines survival time of tumor-bearing mice. Proc. Natl. Acad. Sci. USA, 96: 15032-15037, 1999.
26. Potter, M., Mushinski, E. B., Wax, J. S., Hartley, J., and Mock, B. A. Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice. Cancer Res., 54: 969-975, 1994.
27. Shepel, L. A., Lan, H., Haag, J. D., Brasic, G. M., Gheen, M. E., Simon, J. S., Hoff, P., Newton, M. A., and Gould, M. N. Genetic identification of multiple loci that control breast cancer susceptibility in the rat. Genetics, 149: 289-299, 1998.
28. Shisa, H., and Hiai, H. Genetically determined susceptibility of Fischer 344 rats to propylnitrosourea-induced thymic lymphomas. Cancer Res., 45: 1483-1487, 1985.
29. van Wezel, T., Stassen, A. P. M., Moen, C. J. A., Hart, A. A. M., van der Valk, M. A., and Demant, P. Genetic interaction and single gene effects in colon tumour susceptibility in mice. Nat. Genet., 14: 468-470, 1996.
30. Wielowieyski, A., Brennan, L. A., and Jongstra, J. Tli1, a resistance locus for carcinogen-induced T-lymphoma. Mamm. Genome, 10: 623-627, 1999.
31. Yamada, Y., Shisa, H., Matsushiro, H., Kamoto, T., Kobayashi, Y., Kawarai, A., and Hiai, H. T lymphomagenesis is determined by a dominant host gene thymic lymphoma susceptible mouse-1 (TLSM-1) in mouse models. J. Exp. Med., 180: 2155-2162, 1994.
32. Yeung, R. S., Buetow, K. H., Testa, J. R., and Knudson, A. G., Jr. Susceptibility to renal carcinoma in the Eker rat involves a tumor suppressor gene on chromosome 10. Proc. Natl. Acad. Sci. USA, 90: 8038-8042, 1993.
33. Boutwell, R. K. Some biological aspects of skin carcinogenesis. Prog. Exp. Tumor Res., 4: 207-250, 1964.
34. DiGiovanni, J. Multistage carcinogenesis in mouse skin. Pharmac. Ther., 54: 63-128, 1992.
35. Naito, M., and DiGiovanni, J. Genetic background and development of skin tumors. In: C. J. Conti, T. J. Slaga, and A. J. P. Klein-Szanto, (eds.), Skin Tumors: Experimental and Clinical Aspects, Vol. 3, pp. 187-212. New York: Raven Press, 1989.
36. Slaga, T. J. Mechanisms involved in two-stage carcinogenesis in mouse skin. In: T. J. Slaga (ed.), Mechanisms of Tumor Promotion, Vol. II, pp. 1-16. Boca Raton, FL: CRC Press, 1984.
37. Bangrazi, C., Mouton, D., Neveu, T., Saran, A., Covelli, V., Dorin, G., and Biozzi, G. Genetics of chemical carcinogenesis. I. Bi-directional selective breeding of susceptible and resistant lines of mice to two-stage skin carcinogenesis. Carcinogenesis (Lond.), 11: 1711-1719, 1990.
38. Saran, S., Neveu, T., Covelli, V., Mouton, D., Pazzaglia, S., Rebessi, S., Doria, G., and Biozzi, G. Genetics of chemical carcinogenesis: analysis of bidirectional selective breeding inducing maximal resistance or maximal susceptibility to 2-stage skin tumorigenesis in the mouse. Int. J. Cancer, 88: 424-431, 2000.
39. Ashman, L. K., Murray, A. W., Cook, M. G., and Kotlarski, I. Two-stage skin carcinogenesis in sensitive and resistant mouse strains. Carcinogenesis (Lond.), 3: 99-102, 1982.
40. DiGiovanni, J., Slaga, T. J., and Boutwell, R. K. Comparison of the tumor-initiating activity of 7,12-demethylbenz[a]anthracene and benzo[a]pyrene in female SENCAR and CD-1 mice. Carcinogenesis (Lond.), 1: 381-389, 1980.
41. DiGiovanni, J., Prichett, W. P., Decina, P. C., and Diamond, L. DBA/2 mice are as sensitive as SENCAR mice to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Carcinogenesis (Lond.), 5: 1493-1498, 1984.
42. DiGiovanni, J., Naito, M., and Chenicek, K. J. Genetic factors controlling susceptibility to skin tumor promotion in mice. In: C. J. Barret, E. Langenbach, and E. Gilmore (eds.), Tumor Promoters: Biological Approaches for Mechanistic Studies and Assay Systems. New York: Raven Press, 1987.
43. Reiners, J. J., Jr., Nesnow, S., and Slaga, T. J. Murine susceptibility to two-stage skin carcinogenesis is influenced by the agent used for promotion. Carcinogenesis (Lond.), 5: 301-307, 1984.
44. Coghlan, L. G., Gimenez-Conti, I., Kleiner, H. E., Fischer, S. M., Rundhaug, J. C., Conti, C. J., Slaga, T. J., and DiGiovanni, J. Development and initial characterization of several new inbred strains of SENCAR mice for studies of multistage skin carcinogenesis. Carcinogenesis (Lond.), 21: 641-646, 2000.
45. Fischer, S., O'Connel, F., Conti, C., Tucker, K., Patrick, K., Adams, L., and Slaga, T. Characterization of an inbred strain of the SENCAR mouse that is highly sensitive to phorbol esters. Carcinogenesis (Lond.), 8: 421-424, 1987.
46. Hennings, H., Lowry, D. T., Yuspa, S. H., Mock, B., and Potter, M. New strains of inbred SENCAR mice with increased susceptibility to induction of papillomas and squamous cell carcinomas in skin. Mol. Carcinog., 20: 143-150, 1997.
47. DiGiovanni, J., Imamoto, A., Naito, M., Walker, S. E., Beltrán, L., Chenicek, K. J., and Skow, L. Further genetic analyses of skin tumor promoter susceptibility using inbred and recombinant inbred mice. Carcinogenesis (Lond.), 13: 525-531, 1992.
48. 1 mice is inherited as an incomplete dominant trait: evidence for multi-locus involvement. Carcinogenesis (Lond.), 9: 639-645, 1988.
49. Angel, J. M., and DiGiovanni, J. Genetics of skin tumor promotion. In: H. Hiai, and O. Hino (eds.), Animal Models of Cancer Predisposition Syndromes, pp. 143-147. Basel: Karger. 1999.
50. Angel, J. M., Caballero, M., and DiGiovanni, J. Confirmation of the mapping of a 12-O-tetradecanoylphorbol-13-acetate promotion susceptibility locus. Psl1, to distal mouse chromosome 9. Mol. Carcinog., 32: 169-175, 2001.
51. Lander, E., and Kruglyak, L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet., 11: 241-247, 1995.